Cargando…
Nano-hydroxyapatite improves intestinal absorption of acetazolamide (BCS Class IV drug)–but how?
We earlier reported that coating poorly water-soluble drugs with nano-hydroxyapatite (nano-HAP) improves bioavailability after oral administration. In the present study, we coated BCS Class IV drug acetazolamide (AZ) with nano-HAP (AZ/HAP formulation), and investigated its bioavailability and nano-H...
Autores principales: | Kaneko, Kenichi, Miyasaka, Ryosuke, Hayman, Roslyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119549/ https://www.ncbi.nlm.nih.gov/pubmed/35588130 http://dx.doi.org/10.1371/journal.pone.0268067 |
Ejemplares similares
-
BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
por: Markovic, Milica, et al.
Publicado: (2020) -
Can nano-hydroxyapatite permeate the oral mucosa? A histological study using three-dimensional tissue models
por: Komiyama, Shogo, et al.
Publicado: (2019) -
Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models
por: Dahlgren, David, et al.
Publicado: (2020) -
Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin
por: Wu, Huiyi, et al.
Publicado: (2014) -
Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap to Improve Their Therapeutic Index
por: Kumar, Sachin, et al.
Publicado: (2018)